Inventor · disambiguated record
Robert W. Siegel
Also filed as: SIEGEL II ROBERT WILLIAM · SIEGEL ROBERT W · SIEGEL ROBERT WILLIAM
13 granted patents·8 pending applications·14 citations·filing 1999–2023
86Inventor score
Top patents by PatentIndex Score
21 records- 0183US8846036B2Antibodies that bind to mammalian NGAL and uses thereofBIRKENMEYER LARRY G·Filed 2008·Granted Sep 30, 2014·5 cites·28 claims
- 0281US8022188B2Immunosuppressant binding antibodies and methods of obtaining and using sameABBOTT LAB·Filed 2007·Granted Sep 20, 2011·7 cites·7 claims
- 0373US12180270B2Anti-ANGPTL 3/8 complex antibodies and methods of using the sameLILLY CO ELI·Filed 2021·Granted Dec 31, 2024·0 cites·16 claims
- 0471US12459997B2Compounds and methods targeting interleukin-19LILLY CO ELI·Filed 2023·Granted Nov 4, 2025·0 cites·2 claims
- 0571US2019162726A1Anti-t. cruzi antibodies and methods of useABBOTT LAB·Filed 2018·Application pending·0 cites
- 0670US11492395B2Polynucleotides for preparing ANGPTL 3/8 complexesLILLY CO ELI·Filed 2021·Granted Nov 8, 2022·0 cites·8 claims
- 0769US2009203037A1Anti-T. Cruzi Antibodies and Methods of UseABBOTT LAB·Filed 2008·Application pending·0 cites
- 0867US11591387B2Compounds and methods targeting interleukin-19LILLY CO ELI·Filed 2020·Granted Feb 28, 2023·0 cites·10 claims
- 0964US11242383B2Anti-ANGPTL ⅜ complex antibodies and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 8, 2022·0 cites·33 claims
- 1064US10919959B2ANGPTL3/8 complexes and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 16, 2021·0 cites·2 claims
- 1164US10215754B2Anti-T. cruzi antibodies and methods of useABBOTT LAB·Filed 2016·Granted Feb 26, 2019·0 cites·6 claims
- 1261US9482667B2Anti-T. cruzi antibodies and methods of useABBOTT LAB·Filed 2015·Granted Nov 1, 2016·0 cites·13 claims
- 1361US9073984B2Anti-T. cruzi antibodies and methods of useBROPHY SUSAN E·Filed 2012·Granted Jul 7, 2015·0 cites·11 claims
- 1459US9453073B2Anti-glucagon antibodies and uses thereofLILLY CO ELI·Filed 2012·Granted Sep 27, 2016·1 cites·8 claims
- 1558US2022146535A1Compounds and methods targeting human tauLILLY CO ELI·Filed 2021·Application pending·0 cites
- 1657US2024059770A1Oxyntomodulin binding molecules, and uses thereofLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1751US2009123946A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 1850US2009124022A1Antibodies that bind to mammalian ngal and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 1949US2009269777A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 2040US2010227775A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2010·Application pending·0 cites
- 2132US6500652B2Use of nucleic acid molecules as antiviral agentsADVANCED RES & TECH INST·Filed 1999·Granted Dec 31, 2002·1 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Robert W. Siegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →